
Sunshine Biopharma Inc (NASDAQ:SBFM) shares are trading lower following a Form424B3 filing. The company stated the filing showed the resale S3 from March 30 is now effective.
Sunshine Biopharma plans to offer on a resale basis an aggregate of 7,207,208 shares of common stock.